Trial Profile
Efficacy evaluation of Tiotropium Respimat with AeroChamber Plus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 01 Jun 2016 Status changed from recruiting to completed.
- 10 Jul 2014 New trial record